Helius Medical Technologies logo
Helius Medical Technologies HSDT
$ 1.92 -4.48%

Quarterly report 2025-Q3
added 11-18-2025

report update icon

Helius Medical Technologies Cash Flow 2011-2026 | HSDT

Annual Cash Flow Helius Medical Technologies

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-10.4 M -14.3 M -13.4 M -11.7 M -21 M -19.6 M -19.3 M -7.94 M -6.32 M -349 K -12 K - -

Depreciation & Amortization

45 K 74 K 112 K 119 K 127 K 59 K 17 K - - - - - -

Accounts Payables

531 K 627 K 1.07 M 747 K 1.68 M 2.39 M 3.48 M - - - - - -

Accounts Receivables

117 K 71 K 66 K 74 K 210 K 275 K 704 K 225 K 8.83 K - - - -

Total Inventories

457 K 589 K 476 K 389 K 598 K 392 K - - - - - - -

All numbers in USD currency

Quarterly Cash Flow Helius Medical Technologies

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - -3.54 M - - - -3 M - - - -3.19 M - -12.2 M -8.35 M -4.68 M - -9.92 M -6.69 M -2.92 M - -9.57 M -6.98 M -3.75 M - -16.5 M -11.2 M -6.8 M - -14.5 M -11.1 M -4.86 M - -14.2 M -9.3 M - - - -2.37 M - - - -3.39 M - - -4.38 M -2.76 M -541 K - - - - - - - - - - - -

Depreciation & Amortization

- - 8 K - 7 K 7 K 9 K - 32 K 38 K 12 K - 47 K 47 K 25 K - 84 K 56 K 28 K - 26 K 29 K 37 K - 43 K 25 K 22 K - 40 K 22 K 10 K - 7 K - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

2.48 M 1.29 M 1.23 M 873 K 743 K 1.29 M 814 K 531 K 497 K 576 K 840 K 627 K 570 K 1.04 M 1.11 M 1.07 M 1.07 M 912 K 1.09 M 747 K 747 K 747 K 747 K 1.68 M 1.68 M 1.68 M 1.68 M 2.39 M 2.39 M 2.39 M 2.39 M 3.48 M 3.48 M 3.48 M 3.48 M 2.16 M 2.16 M 2.16 M - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

- 12 K - 70 K 25 K 121 K 49 K 117 K 94 K 144 K 11 K 71 K 21 K 9 K 60 K 66 K 23 K 51 K 49 K 74 K 74 K 74 K 74 K 210 K 210 K 210 K 210 K 177 K 177 K 177 K 177 K 704 K 704 K 704 K 704 K 225 K 225 K 225 K 225 K 122 K 116 K 24.2 K 8.83 K - - - - - - - - - - - - - - - -

Total Inventories

1.13 M 1.14 M 1.11 M 1.04 M 774 K 821 K 384 K 457 K 521 K 563 K 617 K 589 K 609 K 577 K 520 K 476 K 538 K 507 K 484 K 389 K 389 K 389 K 389 K 598 K 598 K 598 K 598 K 392 K 392 K 392 K 392 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Helius Medical Technologies, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Medical devices sector

Issuer Price % 24h Market Cap Country
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Align Technology Align Technology
ALGN
$ 164.69 -7.13 % $ 12.3 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Sintx Technologies Sintx Technologies
SINT
$ 2.32 -4.13 % $ 6.43 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
$ 3.8 -5.24 % $ 62 M usaUSA
Stryker Corporation Stryker Corporation
SYK
$ 328.87 -1.15 % $ 126 B usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 10.95 -4.99 % $ 1.64 B usaUSA
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 26.55 -0.86 % $ 607 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.66 -11.27 % $ 31 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 105.12 0.53 % $ 183 B usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 21.37 -8.36 % $ 1.45 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 69.36 -1.15 % $ 103 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 35.31 -3.63 % $ 1.1 B usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Viemed Healthcare Viemed Healthcare
VMD
$ 9.26 0.43 % $ 360 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.59 -1.05 % $ 32.1 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 2.19 -3.52 % $ 3.42 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 10.81 0.23 % $ 448 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 78.73 -4.1 % $ 46 B usaUSA
Vivos Therapeutics Vivos Therapeutics
VVOS
$ 1.13 -5.04 % $ 5.67 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Beyond Air Beyond Air
XAIR
$ 0.69 -0.72 % $ 46.7 M usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
$ 0.57 0.51 % $ 76.2 M usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
$ 88.4 -0.85 % $ 18 B usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 11.24 -1.49 % $ 1.52 B usaUSA
Penumbra Penumbra
PEN
$ 335.31 -0.33 % $ 13 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 15.72 -3.85 % $ 369 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
- 10.0 % $ 610 K usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
- - $ 16 M usaUSA